EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metabolic Characterization of Cerebrospinal Fluid for Patients With Autoimmune Encephalitis: A Preliminary Study

Xiaolong Li iD, Xiaoxiao Qin, Yuan Xie, Lingyun Wang, Jinwen Wang, Shushen Ji, Huihui Jiang iD, Qun Wang iD

CNS Neuroscience & Therapeutics · 2025

DOI: 10.1111/cns.70203 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2025. Verfasst von Xiaolong Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Encephalitis, Biomarkers. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovative Research Program of Xiangyang No.1 People's Hospital, Natural Science Foundation of Beijing Municipality, Capital Health Research and Development of Special grants.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Metabolomics offers promise in uncovering potential biomarkers and understanding the pathophysiology of autoimmune encephalitis (AE), which is a cluster of disorders with the host immune system targeting self‐antigens expressed in the central nervous system (CNS). In this research, our objective was to explore metabolic characterization in cerebrospinal fluid (CSF) from individuals with AE, aiming to shed light on the pathophysiology of AE.

Methods

A targeted approach was applied using an ultra‐performance liquid chromatography coupled to tandem mass spectrometry (UPLC–MS/MS) system to study CSF metabolites in patients with AE ( n = 18), and control subjects without neurological diseases ( n = 17).

Results

A total of 21 potential biomarkers were acquired by getting the intersection of the differential metabolites from univariate statistics and multidimensional statistics between the AE (cell‐based assay panel, CBA‐panel) group and the control group. Specifically, the levels of pyruvic acid and oxoglutaric acid were notably elevated in the AE(CBA‐panel) group compared to those in the control group, indicating that the dysregulated TCA cycle may play a pivotal role in the progression of AE(CBA‐panel). Interestingly, 27 potential biomarkers were acquired by getting the intersection of the differential metabolites from univariate statistics and multidimensional statistics between the anti‐N‐methyl‐D‐aspartate receptor encephalitis (NMDARE) group and the control group, suggesting that the disparities between patients with greater homogeneity and the controls are amplified. In addition, seven differential metabolites were identified by the univariate statistics between the AE (tissue‐based assay, TBA) group and the control group, including alpha‐linolenic acid and gamma‐linolenic acid, suggesting that dysregulated biosynthesis of unsaturated fatty acids and alpha‐linolenic acid metabolism might be crucial in the AE(TBA) disease course.

Conclusion

Collectively, distinct metabolic profiles were evident in the CSF of the AE group compared to the control group, notably involving metabolites associated with mitochondrial dysfunction, which helped to elucidate the pathophysiology of AE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EncephalitisBiomarkersHumansFemaleMaleAdultMiddle AgedHashimoto DiseaseMetabolomicsAgedTandem Mass SpectrometryYoung AdultChromatography, High Pressure Liquid

Stichwörter der Autor:innen

autoimmune encephalitisbiomarkercerebrospinal fluidmetabolomicspathophysiology

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Department of Neurology, Xiangyang No. 1 People's Hospital, Hubei University of Medicine, Xiangyang, Hubei, China.
  • Zhangjiang Center for Translational Medicine, Shanghai Biotecan Pharmaceuticals co. Ltd., Shanghai, China.
  • National Center for Clinical Medicine of Neurological Diseases, Beijing, China.
  • Beijing Institute of Brain Disorders, Collaborative Innovation Center for Brain Disorders, Capital Medical University, Beijing, China.

ORCID-Profile: Xiaolong Li, Huihui Jiang, Qun Wang

Förderung

  • Innovative Research Program of Xiangyang No.1 People's Hospital
  • Natural Science Foundation of Beijing Municipality
  • Capital Health Research and Development of Special grants
  • The National Key R&D Program of China grant

Zitieren

APA

Li, X., Qin, X., Xie, Y., Wang, L., Wang, J., Ji, S., Jiang, H., & Wang, Q. (2025). Metabolic Characterization of Cerebrospinal Fluid for Patients With Autoimmune Encephalitis: A Preliminary Study. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.70203

Vancouver

Li X, Qin X, Xie Y, Wang L, Wang J, Ji S, et al. Metabolic Characterization of Cerebrospinal Fluid for Patients With Autoimmune Encephalitis: A Preliminary Study. CNS Neuroscience & Therapeutics. 2025. doi:10.1111/cns.70203

BibTeX
@article{Li2025,
  author = {Li, Xiaolong and Qin, Xiaoxiao and Xie, Yuan and Wang, Lingyun and Wang, Jinwen and Ji, Shushen and Jiang, Huihui and Wang, Qun},
  title = {Metabolic Characterization of Cerebrospinal Fluid for Patients With Autoimmune Encephalitis: A Preliminary Study},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2025},
  doi = {10.1111/cns.70203}
}
Kostenlos starten →